The Kaplan–Meier analysis indicated that GBM patients with high expression of CARHSP1, KIAA0895, FBMIL1, and STRA6 exhibited worse overall survival as compared to patients with low expression of these genes (P = 0.0, P = 4e−04, P = 0.041, P = 2e−04, log-rank test, Fig. 2C). This evidence concerns the gene MATCAP2 and glioblastoma.